Skip to content
Medical Health Aged Care

New ‘Matters of Life and Death’ materials to raise awareness

Palliative Care Australia 2 mins read
The designs feature real people currently working or volunteering in palliative care and really highlight the 'people at the heart of quality palliative care'.

Palliative Care Australia has launched a series of videos and communication materials aimed at raising awareness of the work the sector does and stimulating end of life conversations and planning.  

“We are building on the success of our campaign during National Palliative Care Week in May, because it’s a message that is relevant every week of the year,” says Camilla Rowland, Chief Executive Office, Palliative Care Australia (PCA). 

“What we found was that people with firsthand experience of palliative care are often our best allies and can play a powerful role in highlighting the benefits of increased access and better understanding of palliative care. 

“Those of us who work or volunteer in palliative care or have experience through a loved one can also help in opening up conversations about what we want the end of our life to look like.” 

Based on the successful 2023 National Palliative Care Week – ‘Matters of Life and Death’ designs, a series of social media tiles, short videos, and associated words and advice can now be easily downloaded from the PCA website and shared via social media. 

The designs feature real people currently working or volunteering in palliative care and really highlight the ‘people at the heart of quality palliative care’. 

“Our collective effort is vital in raising awareness, increasing access, and recognising the contribution of nurses, doctors, allied health professionals, volunteers, and carers,” Ms Rowland says. 

“Anyone can become an ally of palliative care, and these communication materials will help get people started within their own networks and community. 

“We are encouraging people to share their experience, start those conversations around death and dying and break down those taboos that often stop us. 

“It’s natural to feel uncomfortable, but our ageing population and increasing understanding of diseases like dementia, MND, Parkinson’s, cancer, and other life limiting illnesses, means that more families will be engaging with palliative care in the future. 

“We are on a trajectory for a 50% increase in demand by 2030 and a doubling in need by 2050, access and understanding need to grow alongside that.” 

To become an ally for palliative care head to the PCA website to download our resources or contact our member organisation in your state or territory. 

Contact details:

Ian Campbell

P: 0417 482 171



More from this category

  • Medical Health Aged Care
  • 30/11/2023
  • 06:05
Royal Australian College of GPs

RACGP calls on Queensland to reduce pressure on hospitals and improve the health of Queenslanders

As Queensland hospitals grapple with devastating ramping, bed shortages, and delays, there has never been a more crucial time for the state to invest in general practice to keep people healthy in the community, says the Royal Australian College of GPs (RACGP). A perfect storm of factors, including an aging population, epidemic of chronic disease, and acute workforce shortages, is putting increasing pressure on Queensland’s hospitals, prompting the RACGP to make its first Budget submission to the state government. RACGP Queensland Chair Dr Cathryn Hester said investment in general practice is key to reducing pressure on Queensland's hospital system. “Queensland’s…

  • General News, Medical Health Aged Care
  • 30/11/2023
  • 06:00
UNSW Sydney

Meet Viv: an AI character fostering companionship for people with dementia

With a view to improving the lives of people living with dementia, UNSW researchers have come up with a world-first: an AI driven companion.…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2023
  • 23:22
Clairvoyant Therapeutics

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (, the clinical-stage pharmaceutical company developing psilocybin therapy for alcohol use disorder (AUD), today announced that it has randomized more than 50 per cent of the expected 128 subjects for its 24-week Phase 2b clinical trial of synthetic psilocybin (25mg oral capsule). The double-blind, randomized controlled trial was initiated in October 2022 and is designed to assess multiple efficacy and safety endpoints."We are pleased that the pace of subject enrollment is at the upper end of our expectations. We are on track for an interim data read out…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.